|
Q1 2021
Filed on May 18, 2021
|
10,000
|
N/A
|
|
|
Q1 2021
Filed on May 18, 2021
|
20,045
|
$96.21 - $109.25
$1.93M - $2.19M
|
|
|
Q1 2021
Filed on May 18, 2021
|
10,016
|
$88.61 - $92.83
$888K - $930K
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
25,791
|
$13.74 - $19.0
$354K - $490K
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
135,787
|
N/A
|
|
Eyepoint Pharmaceuticals Inc
|
Q4 2020
Filed on Feb 16, 2021
|
202,366
|
N/A
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
651
|
$343.51 - $421.75
$224K - $275K
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
4,825
|
$44.43 - $55.67
$214K - $269K
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
8,695
|
$50.52 - $50.58
$439K - $440K
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
124,267
|
$0.64 - $1.36
$79.5K - $169K
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
2,000
|
$155.16 - $163.36
$310K - $327K
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
20,000
|
N/A
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
34,571
|
N/A
|
|
Houghton Mifflin Harcourt CO
|
Q4 2020
Filed on Feb 16, 2021
|
10,000
|
N/A
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
30,000
|
$7.23 - $32.5
$217K - $975K
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
20,000
|
$18.23 - $23.58
$365K - $472K
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
32,209
|
N/A
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
5,133
|
$14.15 - $16.1
$72.6K - $82.6K
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
538
|
$7.75 - $11.07
$4.17K - $5.96K
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
1,050
|
$9.75 - $15.34
$10.2K - $16.1K
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
861
|
$23.59 - $31.45
$20.3K - $27.1K
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
1,257
|
$10.77 - $16.21
$13.5K - $20.4K
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
2,282
|
$60.3 - $61.57
$138K - $141K
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
1,273
|
$54.69 - $55.09
$69.6K - $70.1K
|
|
Xtrackers Japan Jpx Nikkei 400 Eq ETF
|
Q3 2020
Filed on Nov 13, 2020
|
2,627
|
N/A
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
23,319
|
$5.72 - $8.44
$133K - $197K
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
4,927
|
$15.74 - $20.02
$77.6K - $98.6K
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
64
|
$13.55 - $16.29
$867 - $1.04K
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
1,280
|
$24.48 - $32.18
$31.3K - $41.2K
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
1,864
|
$6.16 - $11.55
$11.5K - $21.5K
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
603
|
N/A
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
620
|
$143.34 - $162.04
$88.9K - $100K
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
8
|
$9.38 - $15.49
$75 - $124
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
23
|
$36.42 - $57.0
$838 - $1.31K
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
500
|
N/A
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
5,000
|
$1.01 - $1.81
$5.05K - $9.05K
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
550
|
$2.32 - $3.47
$1.28K - $1.91K
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
311
|
$23.03 - $32.87
$7.16K - $10.2K
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
1,953
|
N/A
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
531
|
$25.74 - $33.04
$13.7K - $17.5K
|
|
Alexion Pharmaceuticals Inc
|
Q3 2020
Filed on Nov 13, 2020
|
50
|
N/A
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
239
|
$85.82 - $97.25
$20.5K - $23.2K
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
2,500
|
$11.31 - $14.22
$28.3K - $35.6K
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
62
|
$57.04 - $62.66
$3.54K - $3.88K
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
200
|
$11.08 - $14.0
$2.22K - $2.8K
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
1,590
|
$77.82 - $89.28
$124K - $142K
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
152
|
N/A
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
197
|
$235.71 - $271.29
$46.4K - $53.4K
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
380
|
$130.31 - $149.79
$49.5K - $56.9K
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
3,975
|
N/A
|
|